Astro-Med, Inc. Directors Declare Quarterly Dividend;; Fourth Quarter and FY2012 Sales and Earnings Report Scheduled for
March 06, 2012 09:30 ET
Astro-Med, Inc. Directors Declare Quarterly Dividend; Fourth Quarter and FY2012 Sales and Earnings Report Scheduled for March 20
WEST WARWICK, RI--(Marketwire - Mar 6, 2012) - Astro-Med, Inc. (
This call is being webcast by Thomson Financial and can be accessed at Astro-Med, Inc's Web site at [ www.Astro-MedInc.com ]. You can participate in the conference call by dialing 877-941-0844 with passcode 4515620. Following the live broadcast, an audio webcast of the call will be available for ten days at [ www.Astro-MedInc.com ]. A replay of the conference call will also be available for seven days by dialing 800-406-7325 with passcode 4515620.
The Astro-Med, Inc. webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at [ www.earnings.com ], Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents ([ www.streetevents.com ]), a password-protected event management site.
Directors Declare Quarterly Dividend
On March 1, 2012, the Directors of Astro-Med, Inc. declared a regular quarterly cash dividend of $0.07 per share, payable on April 2, 2012, to shareholders of record March 16, 2012 for the Fourth Quarter, which ended on January 31, 2012.
About Astro-Med, Inc.
Astro-Med, Inc. is a leading manufacturer of specialty high tech printing systems, electronic medical instrumentation, and test and measurement instruments. Astro-Med, Inc. products sold under the brand names Astro-Med®, Grass® Technologies and QuickLabel® Systems and are employed around the world in a wide range of aerospace, medical, military, industrial, and packaging applications. Astro-Med, Inc. is a member of the Russell Microcap® Index. Additional information is available by visiting [ www.Astro-MedInc.com ].
Safe Harbor Statement
This news release contains forward-looking statements, and actual results may vary from those expressed or implied herein. Factors that could affect these results include those mentioned in Astro-Med's FY2011 annual report and its annual and quarterly filings with the Securities and Exchange Commission.